Sleep paralysis is a clinical phenomenon that is often a feature of narcolepsy. As its co-existence with panic disorder has not been noted before, we report on two cases in which the two conditions co-exist and postulate a neurochemical mechanism.
Charney D.S., Heninger G.R. (1986) Abnormal regulation of noradrenergic function in panic disorders. Am J Psychiatr43: 1042-1054
2.
Charney D.S., Menkes D.B., Heninger G.R. (1981) Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatr38: 1160-1180
3.
Fruhstorfer B., Mignot E., Bowersox S., Nishino S., Dement W.C., Guilleminault C. (1989) Canine narcolepsy is associated with an elevated number of alpha 2 adrenoceptors in the locus coeruleus. Brain Res500: 209-214
4.
Lishman W.A. (1987) Organic psychiatry. The psychological consequences of cerebral disorder. Oxford, Blackwell , p. 623
5.
Lydiard R.B. (1987) Preliminary results of an open, fixed dose study of desipramine in panic disorder. Psychopharmacol Bull23: 113-114
6.
Nishino S., Haak L., Shepherd H., Guilleminault C., Sakai T., Dement W.C., Mignot E. (1990) Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep. J Pharmacol Exp Ther253: 1145-1152
7.
Nutt D.J. (1989) Altered alpha-2-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatr46: 165-169
8.
Nutt D.J., Glue P. ( 1989) Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Pharmacol Ther44: 307-334
9.
Nutt D.J., Lawson C. (1992) Panic attacks. A neurochemical overview of models and mechanisms. Br J Psychiatr160: 165-178
10.
Rifkin A., Klein D.F., Dillon D.J., Levitt M. (1981) Blockade by imipramine or desipramine of panic induced by sodium lactate. Am J Psychiatr138: 676-677
